RAYMED LABS LTD.

Cresanto Global Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the un-audited financial results for the second quarter ended September 30, 2026. The meeting will also include noting the Limited Review Report for the same period. Additionally, the company has informed about a trading window closure for designated persons from October 1, 2026, to November 7, 2026, to prevent insider trading around the financial results announcement.

Cresanto Global Ltd has announced the closure of its trading window for the second quarter ended September 30, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 1, 2026, until 48 hours after the Unaudited Financial Results for the quarter are made public. All designated persons and their immediate relatives are advised not to trade in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.

Cresanto Global Ltd (formerly Raymed Labs Limited) announced that all five resolutions presented at its Annual General Meeting (AGM) held on August 31, 2026, were passed with the requisite majority. The voting was conducted through remote e-voting and e-voting. The company submitted the Scrutinizer's Report and Voting Results, dated September 1, 2026, prepared by M/s. Nidhi Bajaj & Associates. The results are also available on the company's website. The meeting commenced at 12:00 PM and concluded at 12:13 PM.

Cresanto Global Ltd announced that its Board of Directors, in a meeting held on August 13, 2026, approved the un-audited financial results for the first quarter ended June 30, 2026. The board also approved the relocation of the company's corporate office and the place for maintaining its books of accounts to Goregaon East, Mumbai. The limited review report for the financial results was also attached. The meeting commenced at 12:30 p.m. and concluded at 1:00 p.m.

Cresanto Global Ltd announced that its Board of Directors, in a meeting held on August 13, 2026, approved the un-audited financial results for the first quarter ended June 30, 2026. The board also approved the corporate office location at 205, 2nd Floor, BLA Business Park, Goregaon East, Mumbai. The meeting commenced at 12:30 p.m. and concluded at 1:00 p.m. The limited review report for the financial results was also attached.

Cresanto Global Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda items include the consideration and approval of the un-audited financial results for the first quarter ended June 30, 2026, and the associated Limited Review Report. Additionally, the board will discuss a change in the company's corporate office and the location for maintaining its books of accounts. A trading window closure for designated persons will be in effect from July 1, 2026, until 48 hours after the results declaration.

Cresanto Global Limited (formerly Raymed Labs Limited) has released its 34th Annual Report for the Financial Year 2025-2026. The report outlines the company's vision to be a trusted global packaging and trading entity, emphasizing high-quality products, customer satisfaction, and reliable service. The company is committed to innovation, operational excellence, and sustainable business practices, including environmentally conscious operations and workforce development. Cresanto Global aims to build long-term relationships and create lasting value for all stakeholders through integrity and transparency. The report details corporate information, financial statements, and various audit reports.

Cresanto Global Ltd has announced the details for its 34th Annual General Meeting (AGM), scheduled for Monday, 31st August, 2026, at 12:00 P.M. IST. The company has fixed Monday, 24th August, 2026, as the relevant date for determining the cut-off for remote e-voting on AGM resolutions. Book closure for the AGM will be from Tuesday, 25th August, 2026, to Monday, 31st August, 2026. E-voting will commence on Friday, 28th August, 2026, at 09:00 A.M. and conclude on Sunday, 30th August, 2026, at 05:00 P.M. This is in compliance with SEBI and Companies Act regulations, with e-voting facilitated through NSDL.

Cresanto Global Ltd (formerly Raymed Labs Limited) has announced its 34th Annual General Meeting (AGM) to be held on Monday, August 31, 2026, at 12:00 p.m. IST via Video Conferencing/Other Audio Visual Means. The meeting agenda includes the adoption of audited financial statements for FY 2025-26, the appointment of a director retiring by rotation, and special business concerning the shifting of the registered office from Uttar Pradesh to Maharashtra, along with the alteration of the Memorandum of Association. The notice of the AGM, along with the Annual Report for FY 2025-26, has been dispatched electronically to shareholders and is available on the company's website.

Cresanto Global Ltd held a board meeting on July 31, 2026, where it approved material related party transactions. These transactions, involving promoters and directors, are for a period from the conclusion of the AGM in FY 26-27 to the AGM in FY 27-28. Each of the four identified related parties, including the Managing Director, is approved for transactions up to ₹5 crores. The meeting also covered disclosures as per SEBI regulations.